MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Teratoma

(UMLS:C0039538)

Definition:: A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642)
UMLS ID:: C0039538
MeSH ID:: D013724

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.465.910

Synonym(s)

Teratoma

TERATOMA

Teratoma NOS

Teratoma, NOS

Teratoma, no ICD-O subtype

Teratoma, no International Classification of Diseases for Oncology subtype

teratoid tumor

teratoid tumors

teratoma

Associated Drug(s)

	Name	Number of Reports	Reference(s)	Data Source
1	Fingolimod Hydrochloride	FAERS: 2		US FAERS
2	Warfarin	FAERS: 2		US FAERS
3	Carbamazepine	FAERS: 1		US FAERS
4	Dasatinib	FAERS: 1		US FAERS
5	Finasteride	FAERS: 1		US FAERS
6	Glatiramer Acetate	FAERS: 1		US FAERS
7	Hydroxyurea	FAERS: 1		US FAERS
8	Methylphenidate	FAERS: 1		US FAERS
9	NuvaRing	FAERS: 1		US FAERS
10	Ortho Evra	FAERS: 1		US FAERS
11	Qlaira	FAERS: 1		US FAERS
12	teriflunomide	FAERS: 1		US FAERS
13	Cyclophosphamide		2859431	CTD
14	Dactinomycin		2859431	CTD
15	Indomethacin	Canada Vigilance: 1		Canada Vigilance
16	Methotrexate		1450620	CTD
17	Quercetin		23918355	CTD
18	Resveratrol		19656070	CTD
19	Temozolomide		19107490	CTD
20	Triprolidine	Canada Vigilance: 1		Canada Vigilance
21	Vincristine		2859431	CTD
22	palbociclib		19164198	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Chordoma	46.7%
2	Germinoma	46.7%
3	Teratocarcinoma	46.7%
4	Neuroectodermal Tumors	44.4%
5	Dysgerminoma	34.4%
6	Seminoma	34.4%
7	Neoplasms, Neuroepithelial	34.4%
8	Gliomatosis cerebri	34.4%
9	Craniopharyngioma	32.6%
10	Neuroectodermal Tumor, Melanotic	32.6%
11	Neuroendocrine Tumors	32.6%
12	leukemia	31%
13	Neoplasms, Glandular and Epithelial	31%
14	melanoma	30.1%
15	Trophoblastic Neoplasms	28.8%
16	Adenoma, Acidophil	27.4%
17	Ganglioneuroma	27.4%
18	Glioma	27.4%
19	Malignant Glioma	27.4%
20	Medulloblastoma	27.3%
21	Paraganglioma	26.9%
22	Carcinoid Tumor	26.1%
23	Neurilemmoma	26.1%
24	Hutchinson's Melanotic Freckle	25.3%
25	Melanoma, Amelanotic	25.3%
26	Pheochromocytoma	24.1%
27	Astrocytoma	24%
28	Ependymoma	24%
29	oligodendroglioma	24%
30	Ganglioglioma	24%
31	gliosarcoma	24%
32	Anaplastic astrocytoma	24%
33	Anaplastic Oligodendroglioma	24%
34	Malignant Carcinoid Syndrome	23.4%
35	Carcinosarcoma	23.1%
36	Hemangiosarcoma	23.1%
37	lymphangiosarcoma	23.1%
38	Glioblastoma	22.3%
39	Neuroblastoma	22.3%
40	Glioblastoma Multiforme	22.3%
41	Ganglioneuroblastoma	21.5%
42	Choriocarcinoma	21.2%
43	Histiocytic Disorders, Malignant	20.5%
44	Melanoma, Experimental	20.4%
45	Adenoma	20%
46	Ameloblastoma	20%
47	Angiokeratoma	20%
48	Carcinoma	20%
49	Hemangioma	20%
50	hemangiopericytoma	20%
51	Lymphangioma	20%
52	Mesenchymoma	20%
53	Nevus	20%
54	Hepatoblastoma	20%
55	Mixed Tumor, Mullerian	20%
56	Angiofibroma	20%
57	Sarcoma	20%
58	Epithelioma	20%
59	Basal cell carcinoma	19.6%
60	Carcinoma, Papillary	19.6%
61	Squamous cell carcinoma	19.6%
62	Chondrosarcoma	19.6%
63	Cystadenoma	19.6%
64	leiomyosarcoma	19.6%
65	liposarcoma	19.6%
66	Mesothelioma	19.6%
67	synovial sarcoma	19.6%
68	Angiomyolipoma	19.6%
69	Clear Cell Sarcoma of Soft Tissue	19.6%
70	Alveolar Soft Part Sarcoma	19.6%
71	Sarcoma, Myeloid	19.6%
72	Carcinoma, Basal Cell	19.6%
73	Carcinoma 256, Walker	18.7%
74	Hamartoma	18.5%
75	Neoplasms, Hormone-Dependent	18.5%
76	Neoplasms, Multiple Primary	18.5%
77	Paraneoplastic Syndromes	18.5%
78	Precancerous Conditions	18.5%
79	Neoplasms, Second Primary	18.5%
80	Carcinoid Heart Disease	18%
81	Cystadenocarcinoma	17.8%
82	Fibrosarcoma	17.8%
83	Osteosarcoma	17.8%
84	Mucoepidermoid Carcinoma	17.8%
85	Meningioma	17.4%
86	Leukemia, Plasma Cell	17.2%
87	Adenofibroma	17%
88	Fibroadenoma	17%
89	Malignant Fibrous Histiocytoma	17%
90	Carcinoma, Ehrlich Tumor	16.9%
91	Carcinoma, Lewis Lung	16.9%
92	Hydatidiform Mole	16.5%
93	Bowen's Disease	16.1%
94	Rhabdomyosarcoma	16.1%
95	Giant Cell Tumor of Bone	16.1%
96	Composite Lymphoma	15.8%
97	Dermatofibrosarcoma	15.3%
98	Dermatofibrosarcoma Protuberans	15.3%
99	Lymphoma	15.3%
100	Retinoblastoma	15.2%
101	Leukemia, Experimental	15.1%
102	Adenocarcinoma	14.8%
103	Carcinoma in Situ	14.8%
104	Carcinoma, Transitional Cell	14.8%
105	Phyllodes Tumor	14.8%
106	Hemangioendothelioma	14.8%
107	Lipoma	14.8%
108	Myoma	14.8%
109	Myxoma	14.8%
110	Neuroma	14.8%
111	Papilloma	14.8%
112	Pseudomyxoma Peritonei	14.8%
113	Papillomatosis	14.8%
114	Angiolipoma	14.8%
115	Myelolipoma	14.8%
116	Neoplasms, Bone Tissue	14.8%
117	Neoplasms, Fibrous Tissue	14.8%
118	Smooth Muscle Tumor	14.8%
119	Adenomatosis, Pulmonary	14.8%
120	Adenomatous Polyps	14.8%
121	Carcinoma, Large Cell	14.8%
122	Carcinoma, Small Cell	14.8%
123	Desmoplastic Small Round Cell Tumor	14.8%
124	Chondroma	14.8%
125	Enchondroma	14.8%
126	Alveolar rhabdomyosarcoma	14.4%
127	Leukemia L1210	14.3%
128	Leukemia P388	14.3%
129	Acanthoma	14.3%
130	Carcinoma, Lobular	13.4%
131	Plasmacytoma	13.3%
132	Malignant histiocytosis	13.2%
133	Histiocytic sarcoma	13.2%
134	Sarcoma 180	12.6%
135	Endometrial Stromal Sarcoma	12.6%
136	Sarcoma, Experimental	12.5%
137	Thymoma	12.4%
138	Leukemia, Radiation-Induced	12.2%
139	Adenoid Cystic Carcinoma	12.2%
140	Cyst	12.2%
141	fibroma	12.2%
142	Fibromatosis	12.2%
143	Neoplastic Processes	12.2%
144	Neoplastic Syndromes, Hereditary	12.2%
145	Osteoblastoma	12.2%
146	Osteoma	12.2%
147	Pregnancy Complications, Neoplastic	12.2%
148	Rhabdomyoma	12.2%
149	Chondromatosis	12.2%
150	Adenocarcinoma, Clear Cell	12.2%
151	Cholangiocarcinoma	12.2%
152	Cervical Intraepithelial Neoplasia	12.2%
153	Hemangioblastoma	12.2%
154	Lymphoma, Extranodal NK-T-Cell	12.2%
155	Neoplasms, Experimental	11.9%
156	Lymphangioleiomyomatosis	11.7%
157	Neurofibrosarcoma	11.6%
158	Acoustic Neuroma	11.3%
159	Vipoma	11%
160	Fibromatosis, Aggressive	10.9%
161	Fibromatosis, Abdominal	10.9%
162	Klatskin Tumor	10.9%
163	Abdominal Neoplasms	10.3%
164	Erythroplasia	10.3%
165	Follicular cyst	10.3%
166	Head and Neck Neoplasms	10.3%
167	Mucocele	10.3%
168	Pilonidal Cyst	10.3%
169	Soft Tissue Neoplasms	10.3%
170	Thoracic Neoplasms	10.3%
171	Thyroglossal Cyst	10.3%
172	Synovial Cyst	10.3%
173	Aberrant Crypt Foci	10.3%
174	Optic Nerve Glioma	10.1%
175	Hodgkin Disease	9.8%
176	Lymphoma, Non-Hodgkin	9.8%
177	Leukemia, Myelomonocytic, Chronic	9.8%
178	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	9.8%
179	Multiple Endocrine Neoplasia	9.2%
180	Neoplasms, Radiation-Induced	8.8%
181	Lymphomatoid Granulomatosis	8.8%
182	Paraneoplastic Encephalomyelitis	8.6%
183	Mammary Neoplasms, Experimental	8.4%
184	Carcinoma, Pancreatic Ductal	8.3%
185	Mastocytoma	8.2%
186	Mastocytosis, Systemic	8.1%
187	Leukemia, Myeloid, Chronic-Phase	8.1%
188	Primary amyloidosis	7.9%
189	Hepatocellular Adenoma	7.9%
190	Basal Cell Nevus Syndrome	7.7%
191	Mastocytosis	7.6%
192	Sturge-Weber Syndrome	7.6%
193	Nephroblastoma	7.5%
194	Gastrointestinal Stromal Tumors	7.4%
195	Hemangioma, Cavernous	7.4%
196	Digestive System Neoplasms	7.3%
197	Endocrine Gland Neoplasms	7.3%
198	Eye Neoplasms	7.3%
199	Leukemia, T-Cell	7.3%
200	Nervous System Neoplasms	7.3%
201	Leukemia, B-Cell	7.3%
202	neurofibroma	7.3%
203	Lymphoma, Follicular	7.3%
204	T-Cell Lymphoma	7.3%
205	Mantle cell lymphoma	7.3%
206	Bone neoplasms	7%
207	Leukoplakia	7%
208	Lymphocele	7%
209	Pancreatic Cyst	7%
210	Skin Neoplasms	7%
211	Hematologic Neoplasms	7%
212	Barrett Esophagus	6.8%
213	Breast Cyst	6.8%
214	Actinic keratosis	6.8%
215	Mediastinal Cyst	6.8%
216	Neoplasm Invasiveness	6.8%
217	Neoplasm Metastasis	6.8%
218	Neoplasm Recurrence, Local	6.8%
219	Parovarian Cyst	6.8%
220	Pericardial Cyst	6.8%
221	Splenic Neoplasms	6.8%
222	Thymic Cyst	6.8%
223	Carcinogenesis	6.8%
224	Myxoid cyst	6.8%
225	Metastasis	6.8%
226	Dermoid Cyst	6.7%
227	Mesoblastic Nephroma	6.7%
228	Retroperitoneal Neoplasms	6.7%
229	Prolactinoma	6.5%
230	Growth Hormone-Secreting Pituitary Adenoma	6.5%
231	Tuberous Sclerosis	6.1%
232	Multiple Endocrine Neoplasia Type 1	6%
233	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	6%
234	Leukemia, Large Granular Lymphocytic	6%
235	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	6%
236	Lymphoma, T-Cell, Cutaneous	6%
237	Lymphoma, AIDS-Related	6%
238	Enteropathy-Associated T-Cell Lymphoma	6%
239	Primary Effusion Lymphoma	6%
240	insulinoma	5.7%
241	Waldenstrom Macroglobulinemia	5.7%
242	Multiple Myeloma	5.7%
243	Dupuytren Contracture	5.6%
244	granulosa cell tumor	5.5%
245	Carcinoma, Ovarian Epithelial	5.5%
246	Urticaria Pigmentosa	5.5%
247	Parathyroid Neoplasms	5.5%
248	Peritoneal Neoplasms	5.5%
249	Thyroid Neoplasm	5.5%
250	Thyroid carcinoma	5.5%
251	Gastrinoma	5.4%
252	Glucagonoma	5.4%
253	Mycosis Fungoides	5.4%
254	Lymphomatoid Papulosis	5.4%
255	Plasmablastic lymphoma	5.4%
256	Adrenocortical carcinoma	5.4%
257	Adenomatous Polyposis Coli	5.1%
258	Corpus Luteum Cyst	5%
259	Ovarian Cysts	5%
260	Liver Neoplasms, Experimental	5%
261	Leydig Cell Tumor	4.9%
262	Tracheal Neoplasms	4.8%
263	Leukoplakia, Oral	4.6%
264	Paraneoplastic Cerebellar Degeneration	4.6%
265	Pancreatic Neoplasm	4.6%
266	Renal Cell Carcinoma	4.6%
267	Papillary Renal Cell Carcinoma	4.6%
268	Mouth Neoplasms	4.5%
269	Central Nervous System Neoplasms	4.5%
270	Vascular Neoplasms	4.5%
271	Thymus Neoplasms	4.5%
272	Nasopharyngeal carcinoma	4.5%
273	Carcinoma, Endometrioid	4.4%
274	Genital Neoplasms, Female	4.4%
275	Pancreatic Pseudocyst	4.4%
276	Lymphatic Metastasis	4.4%
277	Neoplasms, Unknown Primary	4.4%
278	Leukemic Infiltration	4.4%
279	Breast Neoplasms, Male	4.4%
280	Neoplasm Micrometastasis	4.4%
281	Triple Negative Breast Neoplasms	4.4%
282	Choledochal Cyst	4.1%
283	Burkitt Lymphoma	4%
284	Peutz-Jeghers Syndrome	4%
285	Thyroid Nodule	3.9%
286	Esophageal Neoplasms	3.9%
287	Limbic Encephalitis	3.8%
288	Denys-Drash Syndrome	3.8%
289	Sezary Syndrome	3.6%
290	Adrenal Gland Neoplasms	3.4%
291	Gastrointestinal Neoplasms	3.4%
292	Genital Neoplasms, Male	3.4%
293	Liver neoplasms	3.4%
294	Uveal Neoplasms	3.4%
295	Urologic Neoplasms	3.4%
296	Lambert-Eaton Myasthenic Syndrome	3.3%
297	Testicular Neoplasms	3.3%
298	Sebaceous Gland Neoplasms	3.3%
299	Spinal Neoplasms	3.3%
300	Bone Marrow Neoplasms	3.3%
301	Meningeal Neoplasms	3.3%
302	Polycystic Ovary Syndrome	3.3%
303	Opsoclonus-Myoclonus Syndrome	2.9%
304	Meningeal Carcinomatosis	2.7%
305	Palatal Neoplasms	2.6%
306	Ear Neoplasms	2.6%
307	Eyelid Neoplasms	2.6%
308	Lung Neoplasms	2.6%
309	Pleural Neoplasms	2.6%
310	Myelitis, Transverse	2.6%
311	Nose Neoplasms	2.6%
312	Cell Transformation, Viral	2.5%
313	Brain Neoplasms	2.5%
314	Salivary Gland Neoplasms	2.5%
315	Spinal Cord Neoplasms	2.5%
316	Tongue Neoplasms	2.5%
317	Uterine Neoplasms	2.4%
318	Vaginal Neoplasms	2.4%
319	Vulvar Neoplasms	2.4%
320	Uterine Cancer	2.4%
321	Fallopian Tube Neoplasms	2.4%
322	Xeroderma Pigmentosum	2.2%
323	Pituitary Adenoma	2.2%
324	Pituitary Neoplasms	2.2%
325	ovarian neoplasm	2.2%
326	Bronchial Neoplasms	2.1%
327	Pharyngeal Neoplasms	2.1%
328	Multiple Pulmonary Nodules	2.1%
329	Supratentorial Neoplasms	2%
330	Central Nervous System Cysts	2%
331	Endometrial Neoplasms	2%
332	Bile Duct Neoplasms	2%
333	gallbladder neoplasm	2%
334	Intestinal Neoplasms	2%
335	Penile Neoplasms	2%
336	Prostatic Neoplasms	2%
337	Stomach Neoplasms	2%
338	Polycythemia Vera	1.9%
339	Brain Stem Neoplasms	1.8%
340	Laryngeal neoplasm	1.7%
341	Choroid Plexus Papilloma	1.7%
342	Hypopharyngeal Neoplasms	1.7%
343	Pleural Effusion, Malignant	1.7%
344	Hypopharyngeal Cancer	1.7%
345	Zollinger-Ellison syndrome	1.6%
346	Bladder Neoplasm	1.6%
347	Kidney Neoplasm	1.6%
348	Ureteral Neoplasms	1.6%
349	Urethral Neoplasms	1.6%
350	Parotid Neoplasms	1.6%
351	Prostatic Neoplasms, Castration-Resistant	1.6%
352	Nelson Syndrome	1.6%
353	Tonsillar Neoplasms	1.5%
354	Cerebellar Neoplasms	1.4%
355	Cecal Neoplasms	1.3%
356	Duodenal Neoplasms	1.3%
357	Radicular Cyst	1.2%
358	Appendiceal Neoplasms	1.2%
359	Colonic Neoplasms	1.2%
360	Rectal Neoplasms	1.2%
361	Nasopharyngeal Neoplasms	1.2%
362	Colorectal Neoplasms	1.2%
363	Paranasal Sinus Neoplasms	1%
364	Anus Neoplasms	1%
365	Sigmoid Neoplasms	1%
366	Maxillary Sinus Neoplasms	0.9%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234